The role of maintenance pemetrexed in the treatment of non-small-cell lung cancer
{{output}}
Until recently, the weight of evidence has supported the discontinuation of chemotherapy in advanced non-small-cell lung cancer (NSCLC) after 4-6 cycles of induction therapy. This allows patients with limited life expectancy a "treatment holiday." A minority o... ...
